[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100319839":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":18,"locations":24,"responsibleParty":97,"collaborators":7,"id":99,"slug":100,"hasResults":101,"nctId":102,"briefTitle":103,"officialTitle":104,"acronym":7,"eligibilityCriteria":105,"healthyVolunteers":101,"sex":106,"minAge":107,"maxAge":7,"enrollmentInfo":108,"targetDuration":111,"studyType":112,"phases":7,"briefSummary":113,"conditions":114,"keywords":116,"overallStatus":27,"whyStopped":7,"lastUpdateSubmitDate":119,"lastUpdatePostDateStruct":120,"startDateStruct":123,"completionDateStruct":125,"leadSponsor":127,"locationsCount":128},{"fullName":5,"class":6},"Sahajanand Medical Technologies Limited","INDUSTRY",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DEVICE","Supraflex Family Sirolimus-eluting Coronary Stent System","Patient implanted with at least one Supraflex Family sirolimus-eluting stent as a part of planned clinical care",[14],{"name":15,"affiliation":16,"role":17},"Dr. A.J.J. IJsselmuiden, MD.","Amphia Hospital, Breda, The Netherlands","PRINCIPAL_INVESTIGATOR",[19],{"name":20,"role":21,"phone":22,"phoneExt":7,"email":23},"Vibhor Bhatia","CONTACT","+919049528863","vibhor.bhatia@sahmed.com",[25,39,48,58,68,78,87],{"facility":26,"status":27,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":7},"Amphia Ziekenhuis","RECRUITING","Breda","North Brabant","4818 CK Breda","Netherlands","NL",{"type":34,"coordinates":35},"Point",[36,37],4.77596,51.58656,{"lat":37,"lon":36},{"facility":40,"status":27,"city":41,"state":29,"zip":42,"country":31,"countryCode":32,"cosmosGeoPoint":43,"geoPoint":47,"contacts":7},"Catharina Ziekenhuis","Eindhoven","5623 EJ",{"type":34,"coordinates":44},[45,46],5.47778,51.44083,{"lat":46,"lon":45},{"facility":49,"status":27,"city":50,"state":51,"zip":52,"country":31,"countryCode":32,"cosmosGeoPoint":53,"geoPoint":57,"contacts":7},"Tergooi Ziekenhuis","Blaricum","North Holland","1261 AN",{"type":34,"coordinates":54},[55,56],5.24167,52.2725,{"lat":56,"lon":55},{"facility":59,"status":27,"city":60,"state":61,"zip":62,"country":31,"countryCode":32,"cosmosGeoPoint":63,"geoPoint":67,"contacts":7},"Medical Center Leeuwarden","Leeuwarden","Provincie Friesland","8934 AD",{"type":34,"coordinates":64},[65,66],5.80973,53.20271,{"lat":66,"lon":65},{"facility":69,"status":27,"city":70,"state":71,"zip":72,"country":31,"countryCode":32,"cosmosGeoPoint":73,"geoPoint":77,"contacts":7},"Albert Schweitzer Ziekenhuis","Dordrecht","South Holland","Post bus 444 3300 AK",{"type":34,"coordinates":74},[75,76],4.67361,51.81,{"lat":76,"lon":75},{"facility":79,"status":27,"city":80,"state":71,"zip":81,"country":31,"countryCode":32,"cosmosGeoPoint":82,"geoPoint":86,"contacts":7},"Maasstad Ziekenhuis","Rotterdam","3079 DZ",{"type":34,"coordinates":83},[84,85],4.47917,51.9225,{"lat":85,"lon":84},{"facility":88,"status":27,"city":89,"state":90,"zip":91,"country":31,"countryCode":32,"cosmosGeoPoint":92,"geoPoint":96,"contacts":7},"ZorgSaam Hospital","Terneuzen","Zeeuws- Vlaanderen","4535 PA",{"type":34,"coordinates":93},[94,95],3.82778,51.33583,{"lat":95,"lon":94},{"type":98,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100319839","s-flex-netherlands-registry-prospective-evaluation-of-the-supraflex-family-sirolimus-eluting-coronary-stent-system-100319839",false,"NCT03443999","S-FLEX Netherlands Registry: Prospective Evaluation of the Supraflex Family Sirolimus-eluting Coronary Stent System","Prospective Evaluation of the Supraflex Family Sirolimus-eluting Coronary Stent System in a 'Real-World' Patient Population","Inclusion Criteria:\n\n1. Age ≥ 18 years\n2. The patient, or legal representative, has been informed of the nature of the registry and has consented to participate and authorised the collection and release of his\u002Fher medical information by signing a Patient Informed Consent Form\n3. Treating physician has electively implanted at least one Supraflex Family stent as part of the patient's planned clinical care.\n4. The patient is willing and able to cooperate with study procedures and required follow up visits\n\nExclusion Criteria:\n\n1. Women with known pregnancy or who are lactating\n2. High probability of non-adherence to the follow-up requirements (due to social, psychological or medical reasons)\n3. Currently participating in another study that has not completed the primary endpoint or that clinically interferes with the current registry requirements\n4. Planned surgery within 6-month of PCI unless dual anti-platelet therapy is maintained throughout the peri-surgical period","ALL","18 Years",{"count":109,"type":110},10000,"ESTIMATED","12 Months","OBSERVATIONAL","The primary objective of this registry is to evaluate the safety and efficacy of the Supraflex Family sirolimus-eluting coronary stent system in a 'real-world' patient population requiring stent implantation.",[115],"Coronary Artery Disease",[115,117,118],"Sirolimus-eluting Stent","Biodegradable Polymers","2026-04-22",{"date":121,"type":122},"2026-04-23","ACTUAL",{"date":124,"type":122},"2018-02-27",{"date":126,"type":110},"2027-12",{"name":5,"class":6},7]